首页 | 本学科首页   官方微博 | 高级检索  
检索        

紫杉醇联合顺铂治疗78例晚期乳腺癌的近期疗效
引用本文:刘健,赵霞,罗锋,陈兆红,刘晓波,林芳.紫杉醇联合顺铂治疗78例晚期乳腺癌的近期疗效[J].华西医学,2004,19(3):397-398.
作者姓名:刘健  赵霞  罗锋  陈兆红  刘晓波  林芳
作者单位:[1]四川大学华西医院教育部人类疾病生物治疗重点实验室与肿瘤中心,四川成都610041 [2]四川大学华西附二院.四川成都610041 [3]四川省德阳市人民医院肿瘤科,四川德阳618000 [4]四川省德阳市第五人民医院肿瘤科,四川德阳618000 [5]四川省内江市第二人民医院肿瘤科,四川内江641000
摘    要:目的:评价紫杉醇联合顺铂对晚期乳腺癌的治疗作用。方法:采用紫杉醇联合顺铂的联合方案,治疗晚期乳腺癌78例,均为初治患者,均经细胞学或病理证实。结果:本组完全缓解CR10.3%8例,部分缓解PR53.8%42例,(CR PR)有效率64%。主要毒性为骨髓抑制及消化道反应、结论:紫杉醇联合顺铂方案是治疗晚期乳腺癌较为理想的方案。

关 键 词:紫杉醇  联合化疗  顺铂  治疗  晚期乳腺癌
文章编号:1002-0179(2004)03-0397-02
修稿时间:2004年3月22日

Short Term Effect of Paclitaxel Combined DDP on Advanced Breast Cancer in 78 Cases
LIU Jian,ZHAO Xia,HE QIU-ming,et al..Short Term Effect of Paclitaxel Combined DDP on Advanced Breast Cancer in 78 Cases[J].West China Medical Journal,2004,19(3):397-398.
Authors:LIU Jian  ZHAO Xia  HE QIU-ming  
Abstract:Objective:To evaluate the effect of paclitaxel combined DDP on advanced breast cancer.Methods:Seventy-eight cases of cytologically and pathologically confirmed advanced breast cancer were treated with combined chemotherapy including paclitaxel and DDP the cardinal drug.All paients received no previous treatment.Results:The complete response was observed in 8 out of 78 patients.Partial response was observed in 42 out of 78 patients.The overall response rate was 64%.Side effects were mainly myelo-suppression and digestive tract reaction.Conclusion:paclitaxel combined DDP regimen is worthy of use in the treatment of advanced breast cancer.
Keywords:Advanced breast cancer  paclitaxel combined DDP
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号